tirzepatide ampoule Injection | Starts at $249/mo Tirzepatide | Origin Amino Research

Long-term success comes from combining the right therapy with clinical oversight, nutrition, behavioral support, and ongoing engagement

PMID: 34243867

Safety Screening and Monitoring Before starting PT-141, patients should undergo a medical evaluation to assess cardiovascular risk, current medications, and overall health status

Interventions Participants were randomly assigned (1:1:1) to receive once-weekly, subcutaneous 10-mg (n = 70) or 15-mg (n = 71) tirzepatide or placebo (n = 69), plus a lifestyle intervention, for 52 weeks

Recent advances in understanding the pathophysiology of IC/BPS have led to the development of novel treatments, which are currently being tested